Last 12 months
Inside the activity.
3 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 3 |
| Dec 2025 | 2 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 19, 2025 Filed Nov 20, 2025 23:02 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
PurchaseCommon Stock | 35,000 | $0.50 | $17,328.50 |
DisclosureSEC source: 0002001162-25-000005 · form4-11202025_111138.xml · nonDerivative · entry 1 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,271,453 F1 · kind: All profits from the reported transactions will be disgorged to the issuer pursuant to applicable requirements. F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.488 to $0.5005. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 21:19 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
SaleCommon Stock | 32,456 | $0.45 | $14,735.02 |
DisclosureSEC source: 0002001162-25-000003 · form4-11192025_091118.xml · nonDerivative · entry 1 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,236,453 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 21:01 UTC |
Carr DouglasSVP Finance & Operations
|
SaleCommon Stock | 292 | $0.59 | $171.11 |
DisclosureSEC source: 0001867173-25-000003 · form4-11052025_091147.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 405,131 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| September 18, 2025 Filed Sep 22, 2025 20:56 UTC |
Cowan ChadChief Scientific Officer
|
GrantCommon Stock | 762,543 | $0.00 | $0.00 |
DisclosureSEC source: 0002039294-25-000004 · form4-09222025_080929.xml · nonDerivative · entry 1 Cowan Chad · CIK 0002039294 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 992,489 F1 · kind: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 50% on October 1, 2026, with the remaining 50% vesting on October 1, 2027, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. Read SEC document |
| September 08, 2025 Filed Sep 10, 2025 21:34 UTC |
Carr DouglasSVP Finance & Operations
|
SaleCommon Stock | 263 | $0.50 | $131.50 |
DisclosureSEC source: 0001062993-25-015526 · form4.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 405,423 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| September 08, 2025 Filed Sep 10, 2025 21:29 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
SaleCommon Stock | 488 | $0.50 | $244.00 |
DisclosureSEC source: 0001062993-25-015525 · form4.xml · nonDerivative · entry 1 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,268,909 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| September 08, 2025 Filed Sep 10, 2025 21:28 UTC |
Russotti GregorySee Remarks
|
SaleCommon Stock | 539 | $0.50 | $269.50 |
DisclosureSEC source: 0001062993-25-015524 · form4.xml · nonDerivative · entry 1 Russotti Gregory · CIK 0001867305 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 391,508 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| August 14, 2025 Filed Aug 18, 2025 20:14 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
GrantCommon Stock | 1,587,614 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-014562 · form4.xml · nonDerivative · entry 1 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,269,397 F1 · kind: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 50% on August 14, 2027, with the remaining 50% vesting on August 14, 2028, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. Read SEC document |
| August 04, 2025 Filed Aug 6, 2025 20:13 UTC |
Carr DouglasSVP Finance & Operations
|
SaleCommon Stock | 296 | $0.53 | $158.06 |
DisclosureSEC source: 0001062993-25-013720 · form4.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 405,686 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 22:26 UTC |
Blackwell KimberlyDirector
|
GrantStock Option (right to buy) · Derivative | 44,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001062993-25-011788 · form4.xml · derivative · entry 1 Blackwell Kimberly · CIK 0001816465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,000 Underlying: Common Stock · 44,000 shares Expires 2035-06-12 F1 · derivative.exercise_date: The option vests on the earlier of (a) June 12, 2026, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 22:26 UTC |
JIMENEZ JOSEPHDirector
|
GrantStock Option (right to buy) · Derivative | 44,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001062993-25-011787 · form4.xml · derivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,000 Underlying: Common Stock · 44,000 shares Expires 2035-06-12 F1 · derivative.exercise_date: The option vests on the earlier of (a) June 12, 2026, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 22:25 UTC |
Riva AlessandroDirector
|
GrantStock Option (right to buy) · Derivative | 44,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001062993-25-011786 · form4.xml · derivative · entry 1 Riva Alessandro · CIK 0001867172 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,000 Underlying: Common Stock · 44,000 shares Expires 2035-06-12 F1 · derivative.exercise_date: The option vests on the earlier of (a) June 12, 2026, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 22:25 UTC |
Carlo RizzutoDirector
|
GrantStock Option (right to buy) · Derivative | 44,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001062993-25-011785 · form4.xml · derivative · entry 1 Carlo Rizzuto · CIK 0001817033 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,000 Underlying: Common Stock · 44,000 shares Expires 2035-06-12 F1 · derivative.exercise_date: The option vests on the earlier of (a) June 12, 2026, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 22:24 UTC |
Quimi DaphneDirector
|
GrantStock Option (right to buy) · Derivative | 44,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001062993-25-011784 · form4.xml · derivative · entry 1 Quimi Daphne · CIK 0001543031 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,000 Underlying: Common Stock · 44,000 shares Expires 2035-06-12 F1 · derivative.exercise_date: The option vests on the earlier of (a) June 12, 2026, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 22:23 UTC |
BUTITTA CYNTHIA MDirector
|
GrantStock Option (right to buy) · Derivative | 44,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001062993-25-011783 · form4.xml · derivative · entry 1 BUTITTA CYNTHIA M · CIK 0001222082 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,000 Underlying: Common Stock · 44,000 shares Expires 2035-06-12 F1 · derivative.exercise_date: The option vests on the earlier of (a) June 12, 2026, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 22:23 UTC |
Walbert Timothy PDirector
|
GrantStock Option (right to buy) · Derivative | 44,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001062993-25-011782 · form4.xml · derivative · entry 1 Walbert Timothy P · CIK 0001349376 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,000 Underlying: Common Stock · 44,000 shares Expires 2035-06-12 F1 · derivative.exercise_date: The option vests on the earlier of (a) June 12, 2026, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 21:05 UTC |
Carr DouglasSVP Finance & Operations
|
SaleCommon Stock | 4,904 | $0.62 | $3,050.29 |
DisclosureSEC source: 0001062993-25-011429 · form4.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 405,982 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 21:05 UTC |
Farid AdrienneChief Operations Officer
|
SaleCommon Stock | 552 | $0.62 | $343.34 |
DisclosureSEC source: 0001062993-25-011428 · form4.xml · nonDerivative · entry 1 Farid Adrienne · CIK 0001867310 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,141 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 21:05 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
SaleCommon Stock | 475 | $0.62 | $295.45 |
DisclosureSEC source: 0001062993-25-011427 · form4.xml · nonDerivative · entry 1 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,681,783 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 21:04 UTC |
Russotti GregorySee Remarks
|
SaleCommon Stock | 526 | $0.62 | $327.17 |
DisclosureSEC source: 0001062993-25-011426 · form4.xml · nonDerivative · entry 1 Russotti Gregory · CIK 0001867305 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,047 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| May 16, 2025 Filed May 20, 2025 20:19 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
SaleCommon Stock | 29,552 | $0.55 | $16,135.39 |
DisclosureSEC source: 0001062993-25-009868 · form4.xml · nonDerivative · entry 1 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,682,258 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| May 05, 2025 Filed May 7, 2025 20:38 UTC |
Farid AdrienneChief Operations Officer
|
SaleCommon Stock | 1,024 | $0.55 | $563.20 |
DisclosureSEC source: 0001062993-25-008775 · form4.xml · nonDerivative · entry 1 Farid Adrienne · CIK 0001867310 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,693 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| May 05, 2025 Filed May 7, 2025 20:38 UTC |
Carr DouglasSVP Finance & Operations
|
SaleCommon Stock | 295 | $0.55 | $162.25 |
DisclosureSEC source: 0001062993-25-008772 · form4.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410,886 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| March 11, 2025 Filed Mar 12, 2025 23:31 UTC |
Cowan ChadChief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 19,500 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001062993-25-005293 · form4.xml · derivative · entry 3 Cowan Chad · CIK 0002039294 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2035-03-11 F3 · derivative.exercise_date: The option vests 25% on March 11, 2026, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| March 11, 2025 Filed Mar 12, 2025 23:31 UTC |
Cowan ChadChief Scientific Officer
|
GrantCommon Stock | 19,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-005293 · form4.xml · nonDerivative · entry 1 Cowan Chad · CIK 0002039294 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,306 F1 · kind: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on March 11, 2026, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. Read SEC document |
| March 11, 2025 Filed Mar 12, 2025 23:31 UTC |
Conn MorganChief Finanical Officer
|
GrantStock Option (right to buy) · Derivative | 19,500 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001062993-25-005294 · form4.xml · derivative · entry 2 Conn Morgan · CIK 0001974124 · Chief Finanical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2035-03-11 F2 · derivative.exercise_date: The option vests 25% on March 11, 2026, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| March 11, 2025 Filed Mar 12, 2025 23:31 UTC |
Conn MorganChief Finanical Officer
|
GrantCommon Stock | 19,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-005294 · form4.xml · nonDerivative · entry 1 Conn Morgan · CIK 0001974124 · Chief Finanical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,648 F1 · security: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on March 11, 2026, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. Read SEC document |
| March 11, 2025 Filed Mar 12, 2025 23:28 UTC |
Russotti GregorySee Remarks
|
GrantStock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001062993-25-005291 · form4.xml · derivative · entry 4 Russotti Gregory · CIK 0001867305 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2035-03-11 F3 · derivative.exercise_date: The option vests 25% on March 11, 2026, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| March 11, 2025 Filed Mar 12, 2025 23:28 UTC |
Russotti GregorySee Remarks
|
GrantCommon Stock | 120,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-005291 · form4.xml · nonDerivative · entry 2 Russotti Gregory · CIK 0001867305 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,573 F2 · kind: Reflects the grant of RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on March 11, 2026, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. Read SEC document |
| March 11, 2025 Filed Mar 12, 2025 23:30 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 521,500 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001062993-25-005292 · form4.xml · derivative · entry 3 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 521,500 Underlying: Common Stock · 521,500 shares Expires 2035-03-11 F3 · derivative.exercise_date: The option vests 25% on March 11, 2026, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| March 11, 2025 Filed Mar 12, 2025 23:30 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
GrantCommon Stock | 521,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-005292 · form4.xml · nonDerivative · entry 2 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,711,810 F2 · kind: Reflects the grant of RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on March 11, 2026, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. Read SEC document |
| March 11, 2025 Filed Mar 12, 2025 23:27 UTC |
Farid AdrienneChief Operations Officer
|
GrantStock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001062993-25-005289 · form4.xml · derivative · entry 3 Farid Adrienne · CIK 0001867310 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2035-03-11 F3 · derivative.exercise_date: The option vests 25% on March 11, 2026, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| March 11, 2025 Filed Mar 12, 2025 23:27 UTC |
Farid AdrienneChief Operations Officer
|
GrantCommon Stock | 120,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-005289 · form4.xml · nonDerivative · entry 2 Farid Adrienne · CIK 0001867310 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 251,717 F2 · kind: Reflects the grant of RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on March 11, 2026, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. Read SEC document |
| March 11, 2025 Filed Mar 12, 2025 23:26 UTC |
Carr DouglasSVP Finance & Operations
|
GrantStock Option (right to buy) · Derivative | 95,625 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001062993-25-005288 · form4.xml · derivative · entry 3 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,625 Underlying: Common Stock · 95,625 shares Expires 2035-03-11 F3 · derivative.exercise_date: The option vests 25% on March 11, 2026, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| March 11, 2025 Filed Mar 12, 2025 23:26 UTC |
Carr DouglasSVP Finance & Operations
|
GrantCommon Stock | 95,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-005288 · form4.xml · nonDerivative · entry 2 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 411,181 F2 · kind: Reflects the grant of RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 25% on March 11, 2026, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 23:28 UTC |
Russotti GregorySee Remarks
|
SaleCommon Stock | 2,360 | $0.62 | $1,451.40 |
DisclosureSEC source: 0001062993-25-005291 · form4.xml · nonDerivative · entry 1 Russotti Gregory · CIK 0001867305 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,573 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 23:30 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
SaleCommon Stock | 2,235 | $0.62 | $1,374.53 |
DisclosureSEC source: 0001062993-25-005292 · form4.xml · nonDerivative · entry 1 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,190,310 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 23:27 UTC |
Farid AdrienneChief Operations Officer
|
SaleCommon Stock | 2,359 | $0.62 | $1,450.79 |
DisclosureSEC source: 0001062993-25-005289 · form4.xml · nonDerivative · entry 1 Farid Adrienne · CIK 0001867310 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,717 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 23:26 UTC |
Carr DouglasSVP Finance & Operations
|
SaleCommon Stock | 1,240 | $0.62 | $762.60 |
DisclosureSEC source: 0001062993-25-005288 · form4.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 315,556 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:00 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
SaleCommon Stock | 34,712 | $0.78 | $27,179.50 |
DisclosureSEC source: 0001062993-25-003043 · form4.xml · nonDerivative · entry 1 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,192,545 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 22:30 UTC |
Carr DouglasSVP Finance & Operations
|
SaleCommon Stock | 351 | $0.78 | $273.78 |
DisclosureSEC source: 0001062993-25-001755 · form4.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 316,796 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 22:31 UTC |
Farid AdrienneChief Operations Officer
|
SaleCommon Stock | 1,054 | $0.78 | $822.12 |
DisclosureSEC source: 0001062993-25-001756 · form4.xml · nonDerivative · entry 1 Farid Adrienne · CIK 0001867310 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,076 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:57 UTC |
Pfeiffenberger BrentDirector · President and CEO
|
Tax withholdingCommon Stock | 243,447 | $1.44 | $350,563.68 |
DisclosureSEC source: 0001062993-24-020202 · form4.xml · nonDerivative · entry 1 Pfeiffenberger Brent · CIK 0002001162 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,227,257 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| November 04, 2024 Filed Nov 5, 2024 21:59 UTC |
Farid AdrienneChief Operations Officer
|
SaleCommon Stock | 1,033 | $1.23 | $1,267.49 |
DisclosureSEC source: 0001062993-24-018339 · form4.xml · nonDerivative · entry 1 Farid Adrienne · CIK 0001867310 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,130 F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| November 04, 2024 Filed Nov 5, 2024 21:59 UTC |
Carr DouglasSVP Finance & Operations
|
SaleCommon Stock | 283 | $1.23 | $347.24 |
DisclosureSEC source: 0001062993-24-018338 · form4.xml · nonDerivative · entry 2 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,147 F2 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:59 UTC |
Carr DouglasSVP Finance & Operations
|
Tax withholdingCommon Stock | 16,611 | $1.26 | $20,929.86 |
DisclosureSEC source: 0001062993-24-018338 · form4.xml · nonDerivative · entry 1 Carr Douglas · CIK 0001867173 · SVP Finance & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,430 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| October 14, 2024 Filed Oct 16, 2024 20:58 UTC |
Conn MorganChief Finanical Officer
|
GrantStock Option (right to buy) · Derivative | 360,890 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001062993-24-017718 · form4.xml · derivative · entry 2 Conn Morgan · CIK 0001974124 · Chief Finanical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 360,890 Underlying: Common Stock · 360,890 shares Expires 2034-10-14 F2 · derivative.exercise_date: The option vests 25% on October 14, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| October 14, 2024 Filed Oct 16, 2024 20:58 UTC |
Conn MorganChief Finanical Officer
|
GrantCommon Stock | 60,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-017718 · form4.xml · nonDerivative · entry 1 Conn Morgan · CIK 0001974124 · Chief Finanical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,148 F1 · security: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the "Company's") common stock. The RSUs vest 25% on October 14, 2025, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 22:04 UTC |
Cowan ChadChief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 446,250 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0001062993-24-017405 · form4.xml · derivative · entry 3 Cowan Chad · CIK 0002039294 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 446,250 Underlying: Common Stock · 446,250 shares Expires 2034-10-01 F3 · derivative.exercise_date: The option vests 25% on October 1, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 22:04 UTC |
Cowan ChadChief Scientific Officer
|
GrantCommon Stock | 74,376 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-017405 · form4.xml · nonDerivative · entry 1 Cowan Chad · CIK 0002039294 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,806 F1 · security: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the "Company's") common stock. The RSUs vest 25% on October 1, 2025, with the remaining 75% vesting on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.